Although brain stimulation techniques are not considered first-line treatments, these are often used in treatment-resistant depression, with electroconvulsive therapy representing the established best therapeutic option for treatment-resistant depression.
Recent shifts in studies of sex and gender reiterate the critical need to tailor mental health care to each patient and to remain mindful about assumptions regarding sex and gender and their role in a given patient’s specific challenges.
Psychiatrists give insight into managing treatment adherence in schizophrenia.
Researchers weigh in on the use of placebo-controlled trials in schizophrenia.
A newly established center at Johns Hopkins is reinvigorating research on the potential therapeutic applications of psychedelics.
As states pass more restrictive abortion laws, some women may become distressed about the various implications of such legislation and seek support from mental health professionals.
Psychosis spectrum disorder as a diagnosis in place of schizophrenia remains controversial, and experts suggest confusion will continue.
Emerging evidence has begun to elucidate the prevalence and outcomes associated with social anxiety disorder in schizophrenia.
For part 2 of this article, Psychiatry Advisor interviewed Dr Brenda L Curtis, whose research focuses on “big data” generated from social networking sites, technology-based interventions for substance use disorders and related issues, and Internet research ethics.
Both depression and rheumatoid arthritis contribute substantially to global disability, and these diseases often co-occur.
